First-line systemic treatment of psoriasis: staying conventional or going biologic?
- PMID: 29052873
- DOI: 10.1111/bjd.15885
First-line systemic treatment of psoriasis: staying conventional or going biologic?
Comment on
-
Secukinumab is superior to fumaric acid esters in treating patients with moderate-to-severe plaque psoriasis who are naive to systemic treatments: results from the randomized controlled PRIME trial.Br J Dermatol. 2017 Oct;177(4):1024-1032. doi: 10.1111/bjd.15707. Epub 2017 Sep 12. Br J Dermatol. 2017. PMID: 28580646 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
